Pathak A - Search Results

1

DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective.

Pathak A, Rohilla A, Gupta T, Akhtar MJ, Haider MR, Sharma K, Haider K, Yar MS. Pathak A, et al. Eur J Med Chem. 2018 Oct 5;158:559-592. doi: 10.1016/j.ejmech.2018.08.093. Epub 2018 Sep 11. Eur J Med Chem. 2018. PMID: 30243157 Review.

2

Medicinal prospects of antioxidants: A review.

Neha K, Haider MR, Pathak A, Yar MS. Neha K, et al. Among authors: pathak a. Eur J Med Chem. 2019 Sep 15;178:687-704. doi: 10.1016/j.ejmech.2019.06.010. Epub 2019 Jun 13. Eur J Med Chem. 2019. PMID: 31228811 Review.

3

Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review.

Haider K, Pathak A, Rohilla A, Haider MR, Ahmad K, Yar MS. Haider K, et al. Among authors: pathak a. Eur J Med Chem. 2019 Dec 15;184:111773. doi: 10.1016/j.ejmech.2019.111773. Epub 2019 Oct 12. Eur J Med Chem. 2019. PMID: 31630053 Review.

4

Recent Progress of Benzimidazole Hybrids for Anticancer Potential.

Akhtar MJ, Yar MS, Sharma VK, Khan AA, Ali Z, Haider MDR, Pathak A. Akhtar MJ, et al. Among authors: pathak a. Curr Med Chem. 2020;27(35):5970-6014. doi: 10.2174/0929867326666190808122929. Curr Med Chem. 2020. PMID: 31393240 Review.

5

Advances in 2-substituted benzothiazole scaffold-based chemotherapeutic agents.

Haider K, Rehman S, Pathak A, Najmi AK, Yar MS. Haider K, et al. Among authors: pathak a. Arch Pharm (Weinheim). 2021 Dec;354(12):e2100246. doi: 10.1002/ardp.202100246. Epub 2021 Aug 31. Arch Pharm (Weinheim). 2021. PMID: 34467567 Review.

6

Emergence of promising novel DPP-4 inhibitory heterocycles as anti-diabetic agents: A review.

Rohilla A, Gupta T, Pathak A, Akhtar MJ, Haider MR, Haider K, Shahar Yar M. Rohilla A, et al. Among authors: pathak a. Arch Pharm (Weinheim). 2018 Jun 7:e1800127. doi: 10.1002/ardp.201800127. Online ahead of print. Arch Pharm (Weinheim). 2018. PMID: 29878387 Review.

7

Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents.

Pathak A, Pandey V, Raj Pokharel Y, Devaraji V, Ali A, Haider K, Saad S, Dewangan RP, Siddiqui N, Shahar Yar M. Pathak A, et al. Bioorg Chem. 2021 Nov;116:105358. doi: 10.1016/j.bioorg.2021.105358. Epub 2021 Sep 16. Bioorg Chem. 2021. PMID: 34544029

8

Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: Formulation perspective and In vitro and In vivo assessment.

Nehal N, Nabi B, Rehman S, Pathak A, Iqubal A, Khan SA, Yar MS, Parvez S, Baboota S, Ali J. Nehal N, et al. Among authors: pathak a. Int J Biol Macromol. 2021 Jan 15;167:605-619. doi: 10.1016/j.ijbiomac.2020.11.207. Epub 2020 Dec 2. Int J Biol Macromol. 2021. PMID: 33278450

9

Strategies in synthetic design and structure-activity relationship studies of novel heterocyclic scaffolds as aldose reductase-2 inhibitors.

Yahya S, Haider K, Pathak A, Choudhary A, Hooda P, Shafeeq M, Shahar Yar M. Yahya S, et al. Among authors: pathak a. Arch Pharm (Weinheim). 2022 Dec;355(12):e2200167. doi: 10.1002/ardp.202200167. Epub 2022 Sep 20. Arch Pharm (Weinheim). 2022. PMID: 36125217 Review.

10

Inhibition of murine thymidylate synthase and human dihydrofolate reductase by 5,8-dideaza analogues of folic acid and aminopterin.

Hynes JB, Patil SA, Tomazic A, Kumar A, Pathak A, Tan XH, Li XQ, Ratnam M, Delcamp TJ, Freisheim JH. Hynes JB, et al. Among authors: pathak a. J Med Chem. 1988 Feb;31(2):449-54. doi: 10.1021/jm00397a031. J Med Chem. 1988. PMID: 3339615

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,743 results

Search Page